nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Dysuria—Epirubicin—stomach cancer	0.00115	0.00166	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—stomach cancer	0.00114	0.00165	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Epirubicin—stomach cancer	0.00114	0.00165	CcSEcCtD
Glycopyrrolate—Urticaria—Fluorouracil—stomach cancer	0.00114	0.00165	CcSEcCtD
Glycopyrrolate—Body temperature increased—Fluorouracil—stomach cancer	0.00113	0.00164	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—stomach cancer	0.00112	0.00162	CcSEcCtD
Glycopyrrolate—Palpitations—Docetaxel—stomach cancer	0.00112	0.00162	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Epirubicin—stomach cancer	0.00111	0.0016	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—stomach cancer	0.0011	0.0016	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Irinotecan—stomach cancer	0.0011	0.0016	CcSEcCtD
Glycopyrrolate—Pneumonia—Epirubicin—stomach cancer	0.0011	0.00159	CcSEcCtD
Glycopyrrolate—Convulsion—Docetaxel—stomach cancer	0.0011	0.00159	CcSEcCtD
Glycopyrrolate—Hypertension—Docetaxel—stomach cancer	0.00109	0.00158	CcSEcCtD
Glycopyrrolate—Drowsiness—Epirubicin—stomach cancer	0.00109	0.00158	CcSEcCtD
Glycopyrrolate—Infestation NOS—Epirubicin—stomach cancer	0.00109	0.00158	CcSEcCtD
Glycopyrrolate—Infestation—Epirubicin—stomach cancer	0.00109	0.00158	CcSEcCtD
Glycopyrrolate—Palpitations—Capecitabine—stomach cancer	0.00109	0.00157	CcSEcCtD
Glycopyrrolate—Asthenia—Irinotecan—stomach cancer	0.00107	0.00155	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00107	0.00155	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Epirubicin—stomach cancer	0.00106	0.00154	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—stomach cancer	0.00106	0.00154	CcSEcCtD
Glycopyrrolate—Hypertension—Capecitabine—stomach cancer	0.00106	0.00153	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Fluorouracil—stomach cancer	0.00106	0.00153	CcSEcCtD
Glycopyrrolate—Dry mouth—Docetaxel—stomach cancer	0.00106	0.00153	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.00106	0.00153	CcSEcCtD
Glycopyrrolate—Sweating—Epirubicin—stomach cancer	0.00105	0.00152	CcSEcCtD
Glycopyrrolate—Confusional state—Docetaxel—stomach cancer	0.00104	0.00151	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00104	0.0015	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—stomach cancer	0.00104	0.0015	CcSEcCtD
Glycopyrrolate—Oedema—Docetaxel—stomach cancer	0.00103	0.0015	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Docetaxel—stomach cancer	0.00103	0.0015	CcSEcCtD
Glycopyrrolate—Epistaxis—Epirubicin—stomach cancer	0.00103	0.00149	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—stomach cancer	0.00103	0.00149	CcSEcCtD
Glycopyrrolate—Infection—Docetaxel—stomach cancer	0.00103	0.00149	CcSEcCtD
Glycopyrrolate—Sinusitis—Epirubicin—stomach cancer	0.00103	0.00149	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—stomach cancer	0.00102	0.00148	CcSEcCtD
Glycopyrrolate—Dry mouth—Capecitabine—stomach cancer	0.00102	0.00148	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—stomach cancer	0.00102	0.00147	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Docetaxel—stomach cancer	0.00101	0.00147	CcSEcCtD
Glycopyrrolate—Pruritus—Fluorouracil—stomach cancer	0.00101	0.00147	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—stomach cancer	0.00101	0.00146	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—stomach cancer	0.00101	0.00146	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—stomach cancer	0.00101	0.00146	CcSEcCtD
Glycopyrrolate—Confusional state—Capecitabine—stomach cancer	0.00101	0.00146	CcSEcCtD
Glycopyrrolate—Tachycardia—Docetaxel—stomach cancer	0.00101	0.00146	CcSEcCtD
Glycopyrrolate—Skin disorder—Docetaxel—stomach cancer	0.00101	0.00145	CcSEcCtD
Glycopyrrolate—Oedema—Capecitabine—stomach cancer	0.001	0.00145	CcSEcCtD
Glycopyrrolate—Infection—Capecitabine—stomach cancer	0.000995	0.00144	CcSEcCtD
Glycopyrrolate—Dizziness—Irinotecan—stomach cancer	0.00099	0.00143	CcSEcCtD
Glycopyrrolate—Rhinitis—Epirubicin—stomach cancer	0.000985	0.00142	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—stomach cancer	0.000984	0.00142	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Capecitabine—stomach cancer	0.000983	0.00142	CcSEcCtD
Glycopyrrolate—Tachycardia—Capecitabine—stomach cancer	0.000978	0.00141	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Epirubicin—stomach cancer	0.000978	0.00141	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—stomach cancer	0.000974	0.00141	CcSEcCtD
Glycopyrrolate—Skin disorder—Capecitabine—stomach cancer	0.000973	0.00141	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—stomach cancer	0.000971	0.0014	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Epirubicin—stomach cancer	0.00097	0.0014	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Capecitabine—stomach cancer	0.000969	0.0014	CcSEcCtD
Glycopyrrolate—Hypotension—Docetaxel—stomach cancer	0.000967	0.0014	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Epirubicin—stomach cancer	0.000966	0.0014	CcSEcCtD
Glycopyrrolate—Urethral disorder—Epirubicin—stomach cancer	0.000963	0.00139	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—stomach cancer	0.000955	0.00138	CcSEcCtD
Glycopyrrolate—Vomiting—Irinotecan—stomach cancer	0.000952	0.00138	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—stomach cancer	0.00095	0.00137	CcSEcCtD
Glycopyrrolate—Dizziness—Fluorouracil—stomach cancer	0.000948	0.00137	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—stomach cancer	0.000946	0.00137	CcSEcCtD
Glycopyrrolate—Rash—Irinotecan—stomach cancer	0.000944	0.00137	CcSEcCtD
Glycopyrrolate—Dermatitis—Irinotecan—stomach cancer	0.000943	0.00136	CcSEcCtD
Glycopyrrolate—Headache—Irinotecan—stomach cancer	0.000938	0.00136	CcSEcCtD
Glycopyrrolate—Hypotension—Capecitabine—stomach cancer	0.000936	0.00135	CcSEcCtD
Glycopyrrolate—Insomnia—Docetaxel—stomach cancer	0.000936	0.00135	CcSEcCtD
Glycopyrrolate—Somnolence—Docetaxel—stomach cancer	0.00092	0.00133	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—stomach cancer	0.00092	0.00133	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—stomach cancer	0.000914	0.00132	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—stomach cancer	0.000914	0.00132	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—stomach cancer	0.000912	0.00132	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—stomach cancer	0.000912	0.00132	CcSEcCtD
Glycopyrrolate—Vomiting—Fluorouracil—stomach cancer	0.000912	0.00132	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—stomach cancer	0.000911	0.00132	CcSEcCtD
Glycopyrrolate—Dyspepsia—Docetaxel—stomach cancer	0.000911	0.00132	CcSEcCtD
Glycopyrrolate—Insomnia—Capecitabine—stomach cancer	0.000906	0.00131	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—stomach cancer	0.000905	0.00131	CcSEcCtD
Glycopyrrolate—Rash—Fluorouracil—stomach cancer	0.000904	0.00131	CcSEcCtD
Glycopyrrolate—Dermatitis—Fluorouracil—stomach cancer	0.000903	0.00131	CcSEcCtD
Glycopyrrolate—Headache—Fluorouracil—stomach cancer	0.000898	0.0013	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—stomach cancer	0.000898	0.0013	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—stomach cancer	0.000895	0.00129	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000894	0.00129	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—stomach cancer	0.000893	0.00129	CcSEcCtD
Glycopyrrolate—Fatigue—Docetaxel—stomach cancer	0.000892	0.00129	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—stomach cancer	0.000891	0.00129	CcSEcCtD
Glycopyrrolate—Nausea—Irinotecan—stomach cancer	0.000889	0.00129	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—stomach cancer	0.000886	0.00128	CcSEcCtD
Glycopyrrolate—Pain—Docetaxel—stomach cancer	0.000885	0.00128	CcSEcCtD
Glycopyrrolate—Constipation—Docetaxel—stomach cancer	0.000885	0.00128	CcSEcCtD
Glycopyrrolate—Dyspepsia—Capecitabine—stomach cancer	0.000882	0.00128	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000865	0.00125	CcSEcCtD
Glycopyrrolate—Fatigue—Capecitabine—stomach cancer	0.000864	0.00125	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—stomach cancer	0.000861	0.00125	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—stomach cancer	0.000861	0.00124	CcSEcCtD
Glycopyrrolate—Constipation—Capecitabine—stomach cancer	0.000857	0.00124	CcSEcCtD
Glycopyrrolate—Pain—Capecitabine—stomach cancer	0.000857	0.00124	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—stomach cancer	0.000855	0.00124	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—stomach cancer	0.000855	0.00124	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Docetaxel—stomach cancer	0.000853	0.00123	CcSEcCtD
Glycopyrrolate—Nausea—Fluorouracil—stomach cancer	0.000852	0.00123	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000846	0.00122	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—stomach cancer	0.000844	0.00122	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—stomach cancer	0.000844	0.00122	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—stomach cancer	0.000843	0.00122	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—stomach cancer	0.000839	0.00121	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—stomach cancer	0.000838	0.00121	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—stomach cancer	0.000831	0.0012	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Capecitabine—stomach cancer	0.000826	0.00119	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000819	0.00119	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—stomach cancer	0.000819	0.00119	CcSEcCtD
Glycopyrrolate—Body temperature increased—Docetaxel—stomach cancer	0.000818	0.00118	CcSEcCtD
Glycopyrrolate—Abdominal pain—Docetaxel—stomach cancer	0.000818	0.00118	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—stomach cancer	0.000806	0.00117	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—stomach cancer	0.000797	0.00115	CcSEcCtD
Glycopyrrolate—Urticaria—Capecitabine—stomach cancer	0.000796	0.00115	CcSEcCtD
Glycopyrrolate—Abdominal pain—Capecitabine—stomach cancer	0.000792	0.00115	CcSEcCtD
Glycopyrrolate—Body temperature increased—Capecitabine—stomach cancer	0.000792	0.00115	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—stomach cancer	0.000792	0.00115	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—stomach cancer	0.000791	0.00114	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—stomach cancer	0.000791	0.00114	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—stomach cancer	0.000786	0.00114	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—stomach cancer	0.00078	0.00113	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—stomach cancer	0.000777	0.00112	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—stomach cancer	0.000775	0.00112	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000773	0.00112	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—stomach cancer	0.000769	0.00111	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Docetaxel—stomach cancer	0.000763	0.0011	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—stomach cancer	0.000756	0.00109	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—stomach cancer	0.000752	0.00109	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—stomach cancer	0.000746	0.00108	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—stomach cancer	0.000746	0.00108	CcSEcCtD
Glycopyrrolate—Asthenia—Docetaxel—stomach cancer	0.000743	0.00107	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—stomach cancer	0.000741	0.00107	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—stomach cancer	0.000741	0.00107	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—stomach cancer	0.000738	0.00107	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Capecitabine—stomach cancer	0.000738	0.00107	CcSEcCtD
Glycopyrrolate—Pruritus—Docetaxel—stomach cancer	0.000732	0.00106	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—stomach cancer	0.000732	0.00106	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—stomach cancer	0.000727	0.00105	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—stomach cancer	0.000725	0.00105	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000723	0.00105	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—stomach cancer	0.000721	0.00104	CcSEcCtD
Glycopyrrolate—Asthenia—Capecitabine—stomach cancer	0.000719	0.00104	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—stomach cancer	0.000712	0.00103	CcSEcCtD
Glycopyrrolate—Pruritus—Capecitabine—stomach cancer	0.000709	0.00103	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—stomach cancer	0.000704	0.00102	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—stomach cancer	0.000699	0.00101	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—stomach cancer	0.000698	0.00101	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—stomach cancer	0.000698	0.00101	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—stomach cancer	0.000697	0.00101	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—stomach cancer	0.000694	0.001	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—stomach cancer	0.000686	0.000992	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—stomach cancer	0.000685	0.00099	CcSEcCtD
Glycopyrrolate—Dizziness—Docetaxel—stomach cancer	0.000684	0.00099	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—stomach cancer	0.000683	0.000988	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—stomach cancer	0.000681	0.000985	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—stomach cancer	0.000678	0.000981	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—stomach cancer	0.000675	0.000976	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—stomach cancer	0.000675	0.000976	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000669	0.000968	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—stomach cancer	0.000663	0.000959	CcSEcCtD
Glycopyrrolate—Dizziness—Capecitabine—stomach cancer	0.000663	0.000958	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—stomach cancer	0.000659	0.000953	CcSEcCtD
Glycopyrrolate—Vomiting—Docetaxel—stomach cancer	0.000658	0.000952	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—stomach cancer	0.000657	0.00095	CcSEcCtD
Glycopyrrolate—Rash—Docetaxel—stomach cancer	0.000653	0.000944	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—stomach cancer	0.000652	0.000943	CcSEcCtD
Glycopyrrolate—Dermatitis—Docetaxel—stomach cancer	0.000652	0.000943	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—stomach cancer	0.000651	0.000942	CcSEcCtD
Glycopyrrolate—Headache—Docetaxel—stomach cancer	0.000648	0.000938	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—stomach cancer	0.000646	0.000934	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—stomach cancer	0.000646	0.000934	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000644	0.000931	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—stomach cancer	0.000643	0.00093	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—stomach cancer	0.000642	0.000928	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—stomach cancer	0.000638	0.000923	CcSEcCtD
Glycopyrrolate—Vomiting—Capecitabine—stomach cancer	0.000637	0.000921	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—stomach cancer	0.000633	0.000916	CcSEcCtD
Glycopyrrolate—Rash—Capecitabine—stomach cancer	0.000632	0.000914	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—stomach cancer	0.000631	0.000913	CcSEcCtD
Glycopyrrolate—Dermatitis—Capecitabine—stomach cancer	0.000631	0.000913	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—stomach cancer	0.00063	0.000912	CcSEcCtD
Glycopyrrolate—Headache—Capecitabine—stomach cancer	0.000628	0.000908	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—stomach cancer	0.000627	0.000907	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—stomach cancer	0.000624	0.000903	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—stomach cancer	0.000621	0.000898	CcSEcCtD
Glycopyrrolate—Nausea—Docetaxel—stomach cancer	0.000615	0.000889	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—stomach cancer	0.000615	0.000889	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—stomach cancer	0.000614	0.000889	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—stomach cancer	0.00061	0.000882	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—stomach cancer	0.000604	0.000873	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000603	0.000872	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—stomach cancer	0.000602	0.00087	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—stomach cancer	0.000597	0.000863	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—stomach cancer	0.000597	0.000863	CcSEcCtD
Glycopyrrolate—Nausea—Capecitabine—stomach cancer	0.000595	0.000861	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—stomach cancer	0.000593	0.000857	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—stomach cancer	0.00059	0.000853	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—stomach cancer	0.00059	0.000853	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—stomach cancer	0.000584	0.000845	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—stomach cancer	0.000575	0.000832	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—stomach cancer	0.000574	0.00083	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000571	0.000826	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—stomach cancer	0.000569	0.000822	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000558	0.000807	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—stomach cancer	0.000557	0.000805	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—stomach cancer	0.000555	0.000802	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—stomach cancer	0.000552	0.000799	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—stomach cancer	0.000552	0.000799	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—stomach cancer	0.000552	0.000798	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—stomach cancer	0.000552	0.000798	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—stomach cancer	0.00055	0.000795	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—stomach cancer	0.000535	0.000774	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—stomach cancer	0.000532	0.00077	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000528	0.000764	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—stomach cancer	0.000528	0.000763	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—stomach cancer	0.000514	0.000744	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—stomach cancer	0.000513	0.000742	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—stomach cancer	0.000511	0.000738	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—stomach cancer	0.000511	0.000738	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—stomach cancer	0.000501	0.000724	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—stomach cancer	0.000494	0.000714	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—stomach cancer	0.000493	0.000713	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—stomach cancer	0.000476	0.000688	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—stomach cancer	0.000474	0.000686	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—stomach cancer	0.00047	0.00068	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—stomach cancer	0.00047	0.00068	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—stomach cancer	0.000467	0.000676	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—stomach cancer	0.000463	0.00067	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—stomach cancer	0.000462	0.000668	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—stomach cancer	0.000457	0.000661	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—stomach cancer	0.000444	0.000642	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—stomach cancer	0.000443	0.000641	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—stomach cancer	0.00044	0.000637	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—stomach cancer	0.00044	0.000636	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—stomach cancer	0.000437	0.000632	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—stomach cancer	0.000427	0.000618	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—stomach cancer	0.000415	0.0006	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—stomach cancer	0.000411	0.000594	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—stomach cancer	0.000407	0.000589	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—stomach cancer	0.000407	0.000588	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—stomach cancer	0.000405	0.000585	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—stomach cancer	0.000384	0.000555	CcSEcCtD
Glycopyrrolate—CHRM2—Signaling Pathways—ANXA1—stomach cancer	7.97e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRB1—stomach cancer	7.82e-05	0.000253	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRB1—stomach cancer	7.79e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FYN—stomach cancer	7.77e-05	0.000252	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRB1—stomach cancer	7.72e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—stomach cancer	7.68e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FGFR2—stomach cancer	7.62e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RPS6—stomach cancer	7.47e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RPS6—stomach cancer	7.44e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPP2R1A—stomach cancer	7.4e-05	0.00024	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RPS6—stomach cancer	7.37e-05	0.000239	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—stomach cancer	7.35e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	7.35e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	7.32e-05	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	7.32e-05	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	7.29e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FGFR2—stomach cancer	7.29e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTP1—stomach cancer	7.26e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PRKCB—stomach cancer	7.25e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6ST—stomach cancer	7.22e-05	0.000234	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HMOX1—stomach cancer	7.16e-05	0.000232	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IRS2—stomach cancer	6.97e-05	0.000226	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HBEGF—stomach cancer	6.86e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HBEGF—stomach cancer	6.84e-05	0.000222	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HBEGF—stomach cancer	6.77e-05	0.00022	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CAV1—stomach cancer	6.76e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOA1—stomach cancer	6.75e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TYMS—stomach cancer	6.75e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IRS2—stomach cancer	6.68e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTM1—stomach cancer	6.67e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6R—stomach cancer	6.53e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6R—stomach cancer	6.51e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	6.49e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CAV1—stomach cancer	6.48e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	6.47e-05	0.00021	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOA1—stomach cancer	6.46e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6R—stomach cancer	6.44e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PRKCB—stomach cancer	6.44e-05	0.000209	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6ST—stomach cancer	6.41e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—RHOA—stomach cancer	6.41e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADRB2—stomach cancer	6.33e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADRB2—stomach cancer	6.31e-05	0.000205	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ERCC2—stomach cancer	6.27e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADRB2—stomach cancer	6.25e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	6.21e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	6.19e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PRKCB—stomach cancer	6.16e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APC—stomach cancer	6.16e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6ST—stomach cancer	6.14e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PPP2R1A—stomach cancer	6.13e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—MAPK3—stomach cancer	5.9e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APC—stomach cancer	5.9e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RHOA—stomach cancer	5.9e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—stomach cancer	5.89e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RHOA—stomach cancer	5.88e-05	0.000191	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RHOA—stomach cancer	5.82e-05	0.000189	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SMAD4—stomach cancer	5.76e-05	0.000187	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SMAD4—stomach cancer	5.74e-05	0.000186	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6R—stomach cancer	5.72e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	5.7e-05	0.000185	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SMAD4—stomach cancer	5.69e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	5.68e-05	0.000184	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—MAPK3—stomach cancer	5.65e-05	0.000183	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—stomach cancer	5.63e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—MAPK1—stomach cancer	5.61e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EGFR—stomach cancer	5.61e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6R—stomach cancer	5.48e-05	0.000178	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FYN—stomach cancer	5.47e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FYN—stomach cancer	5.45e-05	0.000177	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—stomach cancer	5.44e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOA1—stomach cancer	5.42e-05	0.000176	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FYN—stomach cancer	5.4e-05	0.000175	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—MAPK1—stomach cancer	5.38e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EGFR—stomach cancer	5.37e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PIK3CA—stomach cancer	5.36e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SERPINE1—stomach cancer	5.36e-05	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—KRAS—stomach cancer	5.3e-05	0.000172	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	5.18e-05	0.000168	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RHOA—stomach cancer	5.17e-05	0.000167	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	5.16e-05	0.000167	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PIK3CA—stomach cancer	5.14e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FGFR2—stomach cancer	5.14e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SERPINE1—stomach cancer	5.13e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FGFR2—stomach cancer	5.12e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—stomach cancer	5.11e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—stomach cancer	5.11e-05	0.000166	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—KRAS—stomach cancer	5.08e-05	0.000165	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FGFR2—stomach cancer	5.07e-05	0.000164	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RHOA—stomach cancer	4.95e-05	0.00016	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—stomach cancer	4.9e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PIK3CA—stomach cancer	4.87e-05	0.000158	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ERBB2—stomach cancer	4.78e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PPARG—stomach cancer	4.78e-05	0.000155	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IRS2—stomach cancer	4.7e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IRS2—stomach cancer	4.69e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PIK3CA—stomach cancer	4.66e-05	0.000151	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IRS2—stomach cancer	4.64e-05	0.00015	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ERBB2—stomach cancer	4.58e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—stomach cancer	4.56e-05	0.000148	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOA1—stomach cancer	4.55e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—stomach cancer	4.55e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—stomach cancer	4.54e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOA1—stomach cancer	4.54e-05	0.000147	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HRAS—stomach cancer	4.51e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—stomach cancer	4.5e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOA1—stomach cancer	4.49e-05	0.000146	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1B—stomach cancer	4.43e-05	0.000144	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—stomach cancer	4.34e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PRKCB—stomach cancer	4.34e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PRKCB—stomach cancer	4.33e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6ST—stomach cancer	4.32e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HRAS—stomach cancer	4.32e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—stomach cancer	4.31e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6ST—stomach cancer	4.31e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—stomach cancer	4.3e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PRKCB—stomach cancer	4.28e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6ST—stomach cancer	4.27e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1B—stomach cancer	4.24e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCND1—stomach cancer	4.23e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—JUN—stomach cancer	4.22e-05	0.000137	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APC—stomach cancer	4.15e-05	0.000135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APC—stomach cancer	4.14e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—stomach cancer	4.13e-05	0.000134	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—stomach cancer	4.11e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—stomach cancer	4.1e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APC—stomach cancer	4.1e-05	0.000133	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1A—stomach cancer	4.09e-05	0.000132	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCND1—stomach cancer	4.05e-05	0.000131	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JUN—stomach cancer	4.04e-05	0.000131	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK8—stomach cancer	3.99e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	3.98e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	3.97e-05	0.000129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—stomach cancer	3.93e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK3—stomach cancer	3.93e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1A—stomach cancer	3.91e-05	0.000127	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6R—stomach cancer	3.86e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6R—stomach cancer	3.84e-05	0.000125	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK8—stomach cancer	3.82e-05	0.000124	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6R—stomach cancer	3.81e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	3.78e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EGFR—stomach cancer	3.78e-05	0.000123	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	3.77e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EGFR—stomach cancer	3.77e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—stomach cancer	3.76e-05	0.000122	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK1—stomach cancer	3.74e-05	0.000121	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EGFR—stomach cancer	3.74e-05	0.000121	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—stomach cancer	3.68e-05	0.000119	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—stomach cancer	3.65e-05	0.000118	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	3.62e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	3.61e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	3.61e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	3.6e-05	0.000117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—KRAS—stomach cancer	3.57e-05	0.000116	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PIK3CA—stomach cancer	3.57e-05	0.000116	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SERPINE1—stomach cancer	3.56e-05	0.000116	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—KRAS—stomach cancer	3.56e-05	0.000115	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—KRAS—stomach cancer	3.53e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—stomach cancer	3.53e-05	0.000114	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—stomach cancer	3.49e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK3—stomach cancer	3.48e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RHOA—stomach cancer	3.48e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RHOA—stomach cancer	3.47e-05	0.000113	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—stomach cancer	3.45e-05	0.000112	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RHOA—stomach cancer	3.44e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—stomach cancer	3.44e-05	0.000111	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—stomach cancer	3.4e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—stomach cancer	3.39e-05	0.00011	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK3—stomach cancer	3.34e-05	0.000108	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK1—stomach cancer	3.32e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EGFR—stomach cancer	3.32e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	3.28e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	3.27e-05	0.000106	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—stomach cancer	3.25e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PIK3CA—stomach cancer	3.24e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ERBB2—stomach cancer	3.23e-05	0.000105	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ERBB2—stomach cancer	3.21e-05	0.000104	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ERBB2—stomach cancer	3.18e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK1—stomach cancer	3.18e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EGFR—stomach cancer	3.17e-05	0.000103	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—KRAS—stomach cancer	3.13e-05	0.000101	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—stomach cancer	3.06e-05	9.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—stomach cancer	3.05e-05	9.88e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HRAS—stomach cancer	3.04e-05	9.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HRAS—stomach cancer	3.03e-05	9.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—stomach cancer	3.02e-05	9.78e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HRAS—stomach cancer	3e-05	9.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—KRAS—stomach cancer	3e-05	9.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.99e-05	9.68e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.98e-05	9.65e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	2.95e-05	9.56e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—stomach cancer	2.91e-05	9.43e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—stomach cancer	2.9e-05	9.4e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	2.88e-05	9.33e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—stomach cancer	2.87e-05	9.3e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCND1—stomach cancer	2.85e-05	9.23e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JUN—stomach cancer	2.84e-05	9.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCND1—stomach cancer	2.84e-05	9.2e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JUN—stomach cancer	2.83e-05	9.19e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCND1—stomach cancer	2.81e-05	9.12e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JUN—stomach cancer	2.81e-05	9.1e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—stomach cancer	2.78e-05	9.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—stomach cancer	2.77e-05	8.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—stomach cancer	2.76e-05	8.94e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	2.76e-05	8.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	2.76e-05	8.93e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	2.75e-05	8.9e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—stomach cancer	2.73e-05	8.85e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	2.72e-05	8.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK8—stomach cancer	2.69e-05	8.72e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK8—stomach cancer	2.68e-05	8.69e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—stomach cancer	2.67e-05	8.64e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HRAS—stomach cancer	2.66e-05	8.63e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK8—stomach cancer	2.66e-05	8.61e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HRAS—stomach cancer	2.55e-05	8.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—stomach cancer	2.55e-05	8.26e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—stomach cancer	2.48e-05	8.05e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—stomach cancer	2.48e-05	8.02e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—stomach cancer	2.46e-05	7.97e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—stomach cancer	2.45e-05	7.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—stomach cancer	2.45e-05	7.95e-05	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—stomach cancer	2.44e-05	7.91e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—stomach cancer	2.43e-05	7.87e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK3—stomach cancer	2.35e-05	7.62e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK3—stomach cancer	2.34e-05	7.59e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK3—stomach cancer	2.32e-05	7.52e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PIK3CA—stomach cancer	2.31e-05	7.5e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—stomach cancer	2.29e-05	7.41e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—stomach cancer	2.28e-05	7.38e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—stomach cancer	2.26e-05	7.31e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK1—stomach cancer	2.24e-05	7.25e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EGFR—stomach cancer	2.24e-05	7.24e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK1—stomach cancer	2.23e-05	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EGFR—stomach cancer	2.23e-05	7.22e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK1—stomach cancer	2.21e-05	7.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EGFR—stomach cancer	2.21e-05	7.15e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—KRAS—stomach cancer	2.11e-05	6.84e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—KRAS—stomach cancer	2.11e-05	6.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—KRAS—stomach cancer	2.08e-05	6.76e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.94e-05	6.29e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.93e-05	6.27e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	1.92e-05	6.21e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—stomach cancer	1.88e-05	6.08e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—stomach cancer	1.87e-05	6.06e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—stomach cancer	1.85e-05	6e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.79e-05	5.82e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.79e-05	5.8e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HRAS—stomach cancer	1.77e-05	5.74e-05	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—stomach cancer	1.72e-05	5.57e-05	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—stomach cancer	1.71e-05	5.55e-05	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—stomach cancer	1.7e-05	5.5e-05	CbGpPWpGaD
